Avecho Biotechnology: Enters supply agreement with Tasmanian Alkaloids
- Avecho Biotechnology has entered a supply agreement with Tasmanian Alkaloids (TasAlk) for the provision of natural medicinal cannabis products
- TasAlk has agreed to supply products to Avecho for research and development
- This agreement follows a supply agreement signed with Purisys to create new oral cannabinoid products
- Avecho develops and commercialises human health, animal health and personal care products using its proprietary drug delivery system, TPM
- TasAlk Chief Operating Officer Doug Blackaby said this agreement is a win-win for both companies
- Avecho is up 50 per cent on the market today, trading for 0.9¢ per share at 12:50 pm AEST
